These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36545453)

  • 41. Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes.
    Yu B; Li C; Sun Y; Wang DW
    Cell Metab; 2021 Jan; 33(1):65-77.e2. PubMed ID: 33248471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metformin as a potential treatment for COVID-19.
    MCCarthy MW
    Expert Opin Pharmacother; 2023; 24(10):1199-1203. PubMed ID: 37194484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in metformin use and other antihyperglycemic therapies after insulin initiation in patients with type 2 diabetes.
    Pilla SJ; Dotimas JR; Maruthur NM; Clark JM; Yeh HC
    Diabetes Res Clin Pract; 2018 May; 139():221-229. PubMed ID: 29524481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetes mellitus and COVID-19: review of a lethal interaction from the cellular and molecular level to the bedside.
    Ali Kazem T; Zeylabi F; Filayih Hassan A; Paridar P; Pezeshki SP; Pezeshki SMS
    Expert Rev Endocrinol Metab; 2022 Jan; 17(1):1-19. PubMed ID: 34781797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus.
    Jing Liang J; Liu J; Chen Y; Ye B; Li N; Wang X; Tang M; Shao J
    Diabetes Res Clin Pract; 2020 Sep; 167():108351. PubMed ID: 32711001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COVID-19 and diabetes: Insulin requirements parallel illness severity in critically unwell patients.
    Wu L; Girgis CM; Cheung NW
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):390-393. PubMed ID: 32683745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.
    Tian J; Liang Y; Qu P
    Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is metformin a miracle or a menace in COVID-19 patients with type 2 diabetes?
    Lui DTW; Tan KCB
    J Diabetes Investig; 2021 Apr; 12(4):479-481. PubMed ID: 33331120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the russian diabetes registry].
    Shestakova MV; Vikulova OK; Isakov MА; Dedov II
    Probl Endokrinol (Mosk); 2020 Aug; 66(1):35-46. PubMed ID: 33351311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
    Feig DS; Donovan LE; Zinman B; Sanchez JJ; Asztalos E; Ryan EA; Fantus IG; Hutton E; Armson AB; Lipscombe LL; Simmons D; Barrett JFR; Karanicolas PJ; Tobin S; McIntyre HD; Tian SY; Tomlinson G; Murphy KE;
    Lancet Diabetes Endocrinol; 2020 Oct; 8(10):834-844. PubMed ID: 32946820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.
    Zhang Y; Zhao Z; Wang S; Zhu W; Jiang Y; Sun S; Chen C; Wang K; Mu L; Cao J; Zhou Y; Gu W; Hong J; Wang W; Ning G
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28609547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metformin versus Insulin in the Management of Pre-Gestational Diabetes Mellitus in Pregnancy and Gestational Diabetes Mellitus at the Korle Bu Teaching Hospital: A Randomized Clinical Trial.
    Beyuo T; Obed SA; Adjepong-Yamoah KK; Bugyei KA; Oppong SA; Marfoh K
    PLoS One; 2015; 10(5):e0125712. PubMed ID: 25945500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An analysis of the relative risk for goitre in euthyroid patients with type 2 diabetes.
    Díez JJ; Iglesias P
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):356-61. PubMed ID: 23414115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
    Bowker SL; Majumdar SR; Veugelers P; Johnson JA
    Diabetes Care; 2006 Feb; 29(2):254-8. PubMed ID: 16443869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
    Avilés-Santa L; Sinding J; Raskin P
    Ann Intern Med; 1999 Aug; 131(3):182-8. PubMed ID: 10428734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.